The cell surface GRP78 is abundant in malignant cells and BBB endothelial cells in vivo and in vitro, leading to the activation of NF-κB signal transduction, which supports the notion that cell-surface GRP78 may be a target for cancer-specific therapy [225,226,227]. This evidence concerns the gene HSPA5 and cancer.